Logo do repositório
 
Publicação

Update on atopic dermatitis

dc.contributor.authorTorres, Tiago
dc.contributor.authorFerreira, Eduarda Osório
dc.contributor.authorGonçalo, Margarida
dc.contributor.authorMendes-Bastos, Pedro
dc.contributor.authorSelores, Manuela
dc.contributor.authorFilipe, Paulo
dc.date.accessioned2023-01-17T14:34:51Z
dc.date.available2023-01-17T14:34:51Z
dc.date.issued2019
dc.description© Ordem dos Médicos 2019pt_PT
dc.description.abstractWith an increasing prevalence during the past decades, atopic dermatitis has become a global health issue. A literature search following a targeted approach was undertaken to perform this non-systematic review, which intends to provide an overview of the epidemiology, pathophysiology, clinical features, comorbidities, and current therapies for the treatment of atopic dermatitis. In sum, this is a heterogeneous skin disorder associated with variable morphology, distribution, and disease course. Although not completely understood, its pathogenesis is complex and seems to result from a combination of genetic and environmental factors that induce skin barrier dysfunction, cutaneous and systemic immune dysregulation, skin microbiota dysbiosis, and a strong genetic influence. Diagnosis is based on specific criteria that consider patient and family history and clinical manifestations. Overall disease severity must be determined by evaluating both objective signs and subjective symptoms. Therapeutic goals require a multistep approach, focusing on reducing pruritus and establishing disease control. Patients should be advised on basic skin care and avoidance of triggers. Topical anti-inflammatory agents should be considered in disease flares or chronic/recurrent lesions. In case of inadequate response, phototherapy, systemic immunosuppressants and, more recently, dupilumab, should be added. Nevertheless, the treatment of moderate-to-severe atopic dermatitis remains challenging and novel, efficacious, safe and targeted treatments are urgently needed. In conclusion, although the last few years have seen important improvement in the understanding of the disease, future research in atopic dermatitis will continue exploring gene-environment interactions and how it affects pathophysiology, disease severity, and treatment outcomes.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationActa Med Port 2019 Sep;32(9):606–613pt_PT
dc.identifier.doi10.20344/amp.11963pt_PT
dc.identifier.eissn1646-0758
dc.identifier.issn0870-399X
dc.identifier.urihttp://hdl.handle.net/10451/55903
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherOrdem dos Médicospt_PT
dc.relation.publisherversionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/indexpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectDermatitis, Atopicpt_PT
dc.subjectComplicationspt_PT
dc.subjectEpidemiologypt_PT
dc.subjectEtiologypt_PT
dc.subjectPrevention and controlpt_PT
dc.subjectTherapypt_PT
dc.titleUpdate on atopic dermatitispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage613pt_PT
oaire.citation.issue9pt_PT
oaire.citation.startPage606pt_PT
oaire.citation.titleActa Médica Portuguesapt_PT
oaire.citation.volume32pt_PT
person.familyNameTorres
person.familyNameFilipe
person.givenNameTiago
person.givenNamePaulo
person.identifier.ciencia-idFF1B-8834-7AE0
person.identifier.ciencia-id171A-309C-C397
person.identifier.orcid0000-0003-0404-0870
person.identifier.orcid0000-0002-7337-6493
person.identifier.scopus-author-id7003448874
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication4710c8a1-f368-44c4-a825-8f64ea981ae2
relation.isAuthorOfPublicationac4119d7-4c3c-471a-9723-f8b8e7543f55
relation.isAuthorOfPublication.latestForDiscovery4710c8a1-f368-44c4-a825-8f64ea981ae2

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Update_atopic.pdf
Tamanho:
296.87 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: